Sleep Apnea, Obstructive Completed Phase 3 Trials for Armodafinil (DB06413)

IndicationStatusPhase
DBCOND0030275 (Sleep Apnea, Obstructive)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00078312Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep DisorderTreatment